Search your symptoms with MEDgle. You can check your symptoms. It is a medical symptom search allowing you find out what options make sense for you.
CLOSE
PATIENT GPS
patients
healthcare providers
how it works
about
login
edit search
new search
symptoms
diagnoses
physicians
drugs
procedures
close
symptoms
diagnoses
drugs
procedures
physicians
symptom duration
0-3 days
4-14 days
2 weeks-2 months
2-6 months
6 months +
add symptom to current symptom search
same as above
0-3 days
4-14 days
2 weeks-2 months
2-6 months
6 months +
add symptom to current symptom search
same as above
0-3 days
4-14 days
2 weeks-2 months
2-6 months
6 months +
add symptom to current symptom search
same as above
0-3 days
4-14 days
2 weeks-2 months
2-6 months
6 months +
gender
male
female
age
1-3
4-11
12-17
18-29
30-50
50+
age
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
calculate
visual
[hide visual search]
search visually
symptoms
|
diagnoses
|
drugs
|
procedures
|
physicians
search symptoms
•
Find causes for your symptoms
•
Discover relevant types of physicians
search diagnoses
•
Understand the details of a diagnosis
•
Learn about relevant tests and treatments
•
Find useful resources on the web
search drugs
•
Learn about different therapeutic drugs
•
Understand what they are used for
•
Know the potential options
search procedures
•
Learn about different diagnostic and therapeutic procedures
•
Understand what they are used for
•
Know the potential options
search physicians
•
Find physicians in your area
•
Understand what they do
•
Get the right help you need
campath
reduced results from
147 billion
82 million
801560
2668
to ~83 options
options split into images, definition, symptoms, related diagnoses, diagnostic tests, therapies, and medications
what is 'campath'?
Definition for Campath - Campath
Alemtuzumab (marketed as Campath , MabCampath or Campath-1H ) is a monoclonal antibody used in the treatment of chronic lymphocytic leukemia (CLL) and T-cell lymphoma .
Alemtuzumab targets CD52 , a protein present on the surface of mature lymphocytes , but not on the stem cells from which these lymphocytes were derived.
more
Alemtuzumab (marketed as Campath , MabCampath or Campath-1H ) is a monoclonal antibody used in the treatment of chronic lymphocytic leukemia (CLL) and T-cell lymphoma .
Alemtuzumab targets CD52 , a protein present on the surface of mature lymphocytes , but not on the stem cells from which these lymphocytes were derived. It is used as second line therapy for CLL. It was approved by the Food and Drug Administration for patients who have been treated with alkylating agents and who have failed fludarabine therapy.
less
diagnoses treated with 'campath'
1 - 2 of
2
diagnosis
chronic lymphocytic leukemia
cancer of white blood cells
web search for:
Campath and chronic lymphocytic leukemia
cytomegalovirus
infection by cytomegalovirus
web search for:
Campath and cytomegalovirus
related procedures when taking 'campath'
1 - 5 of
58
procedures
Blood, Platelet Count
Platelet Count
web search for:
Campath and Blood, Platelet Count
CT chest
web search for:
Campath and CT chest
CT scan
web search for:
Campath and CT scan
Cerebrospinal Fluid analysis
web search for:
Campath and Cerebrospinal Fluid analysis
Complete Blood Count
web search for:
Campath and Complete Blood Count
ABO Blood Groups
web search for:
Campath and ABO Blood Groups
Abdominal CAT Scan
web search for:
Campath and Abdominal CAT Scan
Abdominal MRI
MRI of abdominal contents
web search for:
Campath and Abdominal MRI
Abdominal ultrasonography
Ultrasound of abdominal contents
web search for:
Campath and Abdominal ultrasonography
Banded chromosome analysis
web search for:
Campath and Banded chromosome analysis
Biopsy bone marrow
web search for:
Campath and Biopsy bone marrow
Blood Transfusion
Transfusion of blood through a vein
web search for:
Campath and Blood Transfusion
Blood Type and Crossmatch
web search for:
Campath and Blood Type and Crossmatch
Bone Marrow Aspiration
web search for:
Campath and Bone Marrow Aspiration
Bone Marrow Transplant
web search for:
Campath and Bone Marrow Transplant
CT Pelvis
web search for:
Campath and CT Pelvis
Central venous catheter
web search for:
Campath and Central venous catheter
Cerebrospinal Fluid opening pressure
web search for:
Campath and Cerebrospinal Fluid opening pressure
Chemotherapy
Use of chemical substances to treat disease
web search for:
Campath and Chemotherapy
Chromosomal analysis
web search for:
Campath and Chromosomal analysis
for more please login, login is free (click to login)
related medication for 'campath'
1 - 5 of
23
drugs
alemtuzumab
web search for:
Campath and alemtuzumab
chlorambucil
web search for:
Campath and chlorambucil
alemtuzumab(campath )
web search for:
Campath and alemtuzumab(campath )
chlorambucil(leukeran )
web search for:
Campath and chlorambucil(leukeran )
cladribine
web search for:
Campath and cladribine
cladribine(leustatin )
web search for:
Campath and cladribine(leustatin )
cyclophosphamide
web search for:
Campath and cyclophosphamide
cyclophosphamide(cytoxan)
web search for:
Campath and cyclophosphamide(cytoxan)
doxorubicin
web search for:
Campath and doxorubicin
fludarabine
web search for:
Campath and fludarabine
fludarabine(fludara , fludarabine phosphate)
web search for:
Campath and fludarabine(fludara , fludarabine phosphate)
g-csf
web search for:
Campath and g-csf
gm-csf
web search for:
Campath and gm-csf
haemophilus vaccine
web search for:
Campath and haemophilus vaccine
mitoxantrone(novantrone , mitoxantrone hydrochloride)
web search for:
Campath and mitoxantrone(novantrone , mitoxantrone hydrochloride)
neisseria meningitides vaccines
web search for:
Campath and neisseria meningitides vaccines
pentostatin
web search for:
Campath and pentostatin
pneumovax
web search for:
Campath and pneumovax
prednisone
web search for:
Campath and prednisone
rituximab
web search for:
Campath and rituximab
for more please login, login is free (click to login)
The following are types of physicians relevant for 'Campath'.
related types of physicians 'family practitioner, hematologist, internist, oncologist'
show local physicians
postal code
Find Local
stars represent relevance to topic not rating
more
The results are computer generated suggestions to help you find a physician. MEDgle does not recommend any particular type of physician or claim to be complete or accurate in the providers and specialties suggested.
web search results for 'campath'?
Results
1 - 50
- alemtuzumab(Campath )
Alemtuzumab - Wikipedia, the free encyclopedia
Alemtuzumab is a recombinant DNA-derived humanized monoclonal antibody (Campath ... The origins of alemtuzumab date back to Campath-1 which was derived from the ...
http://en.wikipedia.org/wiki/Campath
en.wikipedia.org
-
summary
Campath (Alemtuzumab) Drug Information: Uses, Side Effects, Drug ...
Learn about the prescription medication Campath (Alemtuzumab), drug uses, dosage, side effects, drug interactions, warnings, and patient labeling.
http://www.rxlist.com/campath-drug.htm
www.rxlist.com
-
summary
ALEMTUZUMAB - INJECTABLE (Campath) side effects, medical uses, and drug ...
Consumer information about the medication ALEMTUZUMAB - INJECTABLE (Campath), includes side effects, drug interactions, recommended dosages, and storage ...
http://www.medicinenet.com/alemtuzumab-injectable/article.htm
www.medicinenet.com
-
summary
Alemtuzumab
Drug details for Alemtuzumab. ... alemtuzumab. Campath, MabCampath. Alemtuzumab is given intravenously or as a shot under the skin. ...
http://www.webmd.com/cancer/alemtuzumab
www.webmd.com
-
summary
Clinical Study: 05-H-0242, A Pilot Study of Alemtuzumab (Campath) in ...
Clinical Study Summary Sheet for 05-H-0242 ... A Pilot Study of Alemtuzumab (Campath) in Patients with Relapsed or Refractory ...
http://clinicalstudies.info.nih.gov/detail/A_2005-H-0242.html
clinicalstudies.info.nih.gov
-
summary
Population pharmacokinetics?pharmacodynamics of alemtuzumab (Campath ...
Alemtuzumab (Campath®) is a 150-kDa humanized IgG1 monoclonal antibody (MAb) ... Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2000651
www.pubmedcentral.nih.gov
-
summary
Alemtuzumab (Campath-1H): a systematic review in organ transplantation.
Alemtuzumab (Campath-1H): a systematic review in organ transplantation. Morris ... Alemtuzumab (Campath-1H) is a powerful antilymphocyte antibody that produces ...
http://www.ncbi.nlm.nih.gov/pubmed/16732169
www.ncbi.nlm.nih.gov
-
summary
Campath consumer information from Drugs.com
Campath patient information. ... Detailed Drug Information for the Consumer > Campath. ALEMTUZUMAB (Systemic) ... becoming pregnant while receiving alemtuzumab. ...
http://www.drugs.com/cons/Campath_Systemic.html
www.drugs.com
-
summary
Alemtuzumab: Drug Information Provided by Lexi-Comp: Merck Manual ...
... I, Jain V, et al, "Therapeutic Role of Alemtuzumab (Campath-1H) in Patients Who ... II Trial of Subcutaneous Anti-CD52 Monoclonal Antibody Alemtuzumab (Campath ...
http://www.merck.com/mmpe/print/lexicomp/alemtuzumab.html
www.merck.com
-
summary
Aplastic Anemia - Evaluation, Treatment and Research at the National ...
The National Heart, Lung and Blood Institute is actively seeking patients with ... Alemtuzumab (Campath) for Refractory or Relapsed Severe Aplastic Anemia ...
http://patientrecruitment.nhlbi.nih.gov/AplasticAnemia.aspx
patientrecruitment.nhlbi.nih.gov
-
summary
Alemtuzumab - Yahoo! Health
Before receiving alemtuzumab, tell your doctor if you have ... Brand Names: Campath. What is the most important information I should know about alemtuzumab? ...
http://health.yahoo.com/leukemia-medications/alemtuzumab/hea...
health.yahoo.com
-
summary
CAMPATH: from concept to clinic
CAMPATH-1H (alemtuzumab) was generated in an attempt to replace anti-lymphocyte ... Watson C.J, et al. Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1569536
www.pubmedcentral.nih.gov
-
summary
ALEMTUZUMAB - INJECTABLE (Campath) side effects, medical uses, and drug ...
Read doctor-produced health and medical information written for you to make informed decisions about ... alemtuzumab-injectable, campath index. alemtuzumab ...
http://www.medicinenet.com/alemtuzumab-injectable/index.htm
www.medicinenet.com
-
summary
Mycobacterium haemophilum Infection after Alemtuzumab Treatment | CDC EID
Immediately before receiving alemtuzumab, he had been given rituximab for 3 months. ... (Campath-1H) in patients who have failed fludarabine: results of a large ...
http://www.cdc.gov/eid/content/14/11/1821.htm
www.cdc.gov
-
summary
Clinical Study: 06-H-0034, A Randomized Study of Three ...
Clinical Study Summary Sheet for 06-H-0034 ... Drug: Alemtuzumab (Campath) Supporting Site: National Heart, Lung and Blood Institute ...
http://clinicalstudies.info.nih.gov/detail/A_2006-H-0034.html
clinicalstudies.info.nih.gov
-
summary
Chronic lymphocytic leukemia (CLL)
Chronic lymphocytic leukemia is a (cancer) of the white blood cells (lymphocytes) characterized by a slow, progressive ... drug alemtuzumab (Campath), which ...
http://adam.about.com/encyclopedia/000532trt.htm
adam.about.com
-
summary
Heterogeneous CD52 expression among hematologic neoplasms: implications ...
... neoplasms: implications for the use of alemtuzumab (CAMPATH-1H) ... The humanized monoclonal antibody alemtuzumab (CAMPATH-1H) is specific for CD52 ...
http://www.ncbi.nlm.nih.gov/pubmed/17145843
www.ncbi.nlm.nih.gov
-
summary
Campath facts and comparsions at Drugs.com
All about Campath. View complete and up to date Campath information - part of ... Campath. Generic Name: Alemtuzumab (AL-em-TOOZ-oo-mab) Brand Name: Campath ...
http://www.drugs.com/cdi/campath.html
www.drugs.com
-
summary
Lymphoma - Evaluation, Treatment and Research at the National Heart ...
The National Heart, Lung and Blood Institute is actively seeking patients with Lymphoma to ... Alemtuzumab (Campath) for T-LGL Lymphoproliferative Disorders ...
http://patientrecruitment.nhlbi.nih.gov/Lymphoma.aspx
patientrecruitment.nhlbi.nih.gov
-
summary
Alemtuzumab in chronic lymphocytic leukemia
Keywords: Alemtuzumab, Campath, chronic lymphocytic leukemia, systematic review, ... alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1899355
www.pubmedcentral.nih.gov
-
summary
Clinical Study: 06-H-0190, Treatment of T-Large Granular Lymphocyte ...
Clinical Study Summary Sheet for 06-H-0190 ... Drug: Alemtuzumab (Campath) Supporting Site: National Heart, Lung and Blood Institute ...
http://clinicalstudies.info.nih.gov/detail/A_2006-H-0190.html
clinicalstudies.info.nih.gov
-
summary
Alemtuzumab - Yahoo! Health
Alemtuzumab is a monoclonal antibody that attaches itself to a protein ... Campath, MabCampath. Alemtuzumab is given intravenously or as a shot under the skin. ...
http://health.yahoo.com/leukemia-medications/alemtuzumab/healthwise--tv7623.html
health.yahoo.com
-
summary
alemtuzumab medical facts from Drugs.com
... reviewed alemtuzumab patient information - includes alemtuzumab description, ... alemtuzumab. Generic Name: alemtuzumab (AL em TOOZ oo mab) Brand Names: Campath ...
http://www.drugs.com/mtm/alemtuzumab.html
www.drugs.com
-
summary
Alemtuzumab (Campath 1H) as successful salvage therapy for recurrent ...
Alemtuzumab (Campath 1H) as successful salvage therapy for recurrent steroid ... The reported use of alemtuzumab in thoracic organ transplant is rare. ...
http://www.ncbi.nlm.nih.gov/pubmed/17613409/
www.ncbi.nlm.nih.gov
-
summary
Cutaneous T cell lymphoma - Wikipedia, the free encyclopedia
Unlike most non-Hodgkin's lymphomas (which are generally B-cell related), CTCL ... Alemtuzumab (Campath-1H) Vorinostat (Zolinza) Methotrexate ...
http://en.wikipedia.org/wiki/Cutaneous_T_cell_lymphoma
en.wikipedia.org
-
summary
Myelodysplastic Syndromes (MDS) - Evaluation, Treatment and Research at ...
The National Heart, Lung and Blood Institute is actively seeking patients with Myelodysplastic ... Alemtuzumab (Campath-1H) for Myelodysplastic Syndrome (MDS) ...
http://patientrecruitment.nhlbi.nih.gov/MDS.aspx
patientrecruitment.nhlbi.nih.gov
-
summary
MedlinePlus Medical Encyclopedia: Chronic lymphocytic leukemia (CLL)
... Iz J K L-Ln Lo-Lz M-Mf Mg-Mz N O P-Pl Pm-Pz Q R S-Sh Si-Sp Sq-Sz T-Tn To ... Alemtuzumab (Campath) is approved for treatment of patients with CLL that has ...
http://www.nlm.nih.gov/medlineplus/ency/article/000532.htm
www.nlm.nih.gov
-
summary
Chronic Lymphocytic Leukemia
Note: Some citations in the text of this section are followed by a level of evidence. ... Alemtuzumab (campath-1H), the monoclonal antibody directed at CD52, has been ...
http://www.webmd.com/cancer/tc/leukemia-chronic-lymphocytic-...
www.webmd.com
-
summary
Pharmacokinetics of alemtuzumab in combination with fludarabine in ...
... monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for ... pharmacodynamics of alemtuzumab (Campath) in patients with chronic lymphocytic ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2625426
www.pubmedcentral.nih.gov
-
summary
Alemtuzumab (Intravenous Route) - MayoClinic.com
Mayo Clinic offers award-winning medical and health information and tools for healthy living. ... Campath. Description. Alemtuzumab is a monoclonal antibody. ...
http://www.mayoclinic.com/health/drug-information/DR601635
www.mayoclinic.com
-
summary
Drugs A-Z List - A on RxList
Browse an A-Z list of Brand and Generic drugs to learn about your prescription medication. ... Alemtuzumab (Campath) Alendronate Sodium (Fosamax) ...
http://www.rxlist.com/drugs/alpha_a.htm
www.rxlist.com
-
summary
Alemtuzumab facts and comparsions at Drugs.com
... about Alemtuzumab. View complete and up to date Alemtuzumab information ... Alemtuzumab. Generic Name: Alemtuzumab (AL-em-TOOZ-oo-mab) Brand Name: Campath ...
http://www.drugs.com/cdi/alemtuzumab.html
www.drugs.com
-
summary
Clinical Study: 03-H-0249, A Randomized Trial of Immunosupression in ...
Clinical Study Summary Sheet for 03-H-0249 ... Drug: Alemtuzumab (Campath-1H) Drug: Thymoglobulin (r-ATG) Drug: Cyclosporine (CsA) ...
http://clinicalstudies.info.nih.gov/cgi/detail.cgi?A_2003-H-0249.html
clinicalstudies.info.nih.gov
-
summary
15114087 2004 04 28 2004 06 30 2004 11 17 0041-1337 77 8 2004 Apr 27 ...
... with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult ... The administration of alemtuzumab (Campath-1H [C1H]; Berlex Laboratories, ...
http://www.ncbi.nlm.nih.gov/pubmed/15114087
www.ncbi.nlm.nih.gov
-
summary
Durable hematologic complete response and suppression of HTLV-1 viral ...
Alemtuzumab is a humanized immunoglobulin G1 ? (IgG1 ?) monoclonal antibody ... alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1895052
www.pubmedcentral.nih.gov
-
summary
Mycobacterium haemophilum Infection after Alemtuzumab Treatment
suppressive agent alemtuzumab is a. DNA-derived, humanized monoclonal ... role of alemtuzumab (Campath-1H) in. patients who have failed ? udarabine: re ...
http://www.cdc.gov/eid/content/14/11/pdfs/1821.pdf
www.cdc.gov
-
summary
MedlinePlus Drug Information: Alemtuzumab Injection
Alemtuzumab injection may cause a decrease in the number of blood cells made by ... Brand names Return to top. Campath® Last Revised - 12/01/2008 ...
http://www.nlm.nih.gov/medlineplus/druginfo/meds/a608053.html
www.nlm.nih.gov
-
summary
PubMedID: 18211507
338-47 Alemtuzumab (CAMPATH-1H) is a depleting agent introduced recently in ... We found that after alemtuzumab induction the recovery of CD8(+) T cells was ...
http://www.ncbi.nlm.nih.gov/pubmed/18211507?ordinalpos=1&ito...
www.ncbi.nlm.nih.gov
-
summary
Chronic lymphocytic leukemia: Treatments and drugs - MayoClinic.com
Chronic lymphocytic leukemia ? Comprehensive overview covers symptoms and ... with chemotherapy drugs, and alemtuzumab (Campath), which is used alone or ...
http://www.mayoclinic.com/health/chronic-lymphocytic-leukemi...
www.mayoclinic.com
-
summary
cytoxan-lyophilized and Campath Drug Interactions
cytoxan-lyophilized and Campath Drug Interactions. Drug-drug and drug-food interactions ... Campath (alemtuzumab) Interaction(s) found: cyclophosphamide ...
http://www.drugs.com/drug-interactions/cytoxan-lyophilized_d...
www.drugs.com
-
summary
Millennium Pharmaceuticals - Wikipedia, the free encyclopedia
... Campath (alemtuzumab) Injection, and additional investigational drugs in clinical trials. ... a strategic business decision, Campath was later sold to the ...
http://en.wikipedia.org/wiki/Millennium_Pharmaceuticals
en.wikipedia.org
-
summary
Leukemia Causes, Diagnosis, Information, Treatments, and Symptoms on ...
alemtuzumab-injectable, Campath. arsenic trioxide-injectable, Trisenox ... alemtuzumab-injectable, Campath. mitoxantrone-injection, Novantrone. busulfan-oral, Myleran ...
http://www.medicinenet.com/script/main/forum.asp?articlekey=...
www.medicinenet.com
-
summary
MedlinePlus - Search Results for: traditional medicine
checked by your doctor, and replaced when necessary. ... Alemtuzumab (Campath) is approved for treatment of ... Goldman L, Ausiello D, eds. ...
http://vsearch.nlm.nih.gov/vivisimo/cgi-bin/query-meta?v%3Af...
vsearch.nlm.nih.gov
-
summary
Pre-transplant ganciclovir and post transplant high-dose valacyclovir ...
Alemtuzumab (Campath-1H)-based conditioning regimens are effective in preventing ... fludarabine 30 mg/m2/day (day -7 to day -3), alemtuzumab 20 mg/day (day -7 to ...
http://www.ncbi.nlm.nih.gov/pubmed/16400339
www.ncbi.nlm.nih.gov
-
summary
Clinical Study: 03-H-0170, Nonmyeloablative Allogeneic Peripheral Blood ...
Clinical Study Summary Sheet for 03-H-0170 ... Alemtuzumab (Campath) Sirolimus (Rapamune) Donor ... Drug: Alemtuzumab (Campath® (Registered Trademark) ...
http://clinicalstudies.info.nih.gov/detail/A_2003-H-0170.html
clinicalstudies.info.nih.gov
-
summary
Kidney Transplantation Under a Tolerogenic Regimen of Recipient ...
... to antibody therapy with muromonab-CD3 (OKT3) or alemtuzumab (Campath 1H) ... of thymoglobulin or with alemtuzumab (Campath 1H) given intraoperatively and on ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1360110
www.pubmedcentral.nih.gov
-
summary
Definition of alemtuzumab - National Cancer Institute Drug Dictionary
alemtuzumab ... Alemtuzumab is an IgG1 kappa with human variable framework and ... Campath. Foreign brand name: MabCampath. Abbreviation: MoAb CD52. Previous: ...
http://www.nci.nih.gov/Templates/drugdictionary.aspx?CdrID=37783
www.nci.nih.gov
-
summary
campath and Arava Drug Interactions
campath and Arava Drug Interactions. Drug-drug and drug-food interactions between campath ... campath (alemtuzumab) Arava (leflunomide) Interaction(s) found: ...
http://www.drugs.com/drug-interactions/campath_d04756_arava_d04349.html
www.drugs.com
-
summary
PMID 11986207
... alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a ... safety, and clinical benefit of alemtuzumab (Campath-1H) for patients with ...
http://www.ncbi.nlm.nih.gov/pubmed/11986207
www.ncbi.nlm.nih.gov
-
summary
Monoclonal antibody drugs for cancer treatment: How they work ...
Monoclonal antibody drugs ? How monoclonal antibodies are being ... Alemtuzumab (Campath) Chronic lymphocytic leukemia. Bevacizumab (Avastin) Breast cancer ...
http://www.mayoclinic.com/health/monoclonal-antibody/CA00082
www.mayoclinic.com
-
summary
show more
1
2
Chat with eNurse Kim about 'Campath' or something else!
quick facts
related diagnosis category
hematological
oncology
infectious diseases
neurology
faq/about
|
disclaimer
|
privacy policy
|
terms of service
|
browse
|
beta
|
contact
|
API - Catalyst
MEDgle does not provide medical advice, diagnosis or treatment. Copyright 2006-2011, MEDgle Inc. All Rights Reserved. MEDgle is NOT affiliated with Google. Last Updated: July 24, 2011
This site complies to the
HONcode standard for trustworthy health
information:
verify here
.
Invited Sponsor for Communications Conference
Finalist -- search & reference
MEDgle has been selected for the 2009 Best of Business Award in the Medical research
Featured Partners:
SEO Services
,
Search Engine Marketing
,
Parenting & Baby Information